Evidence map›Paper›PMID 40474034›Full record

ReviewAmerican journal of clinical dermatology2025

Is There a Place for Biologics in Acne?

Lajos Kemény, Döníz Degovics, Kornélia Szabó

Abstract readReview
In one paragraph

Review in American journal of clinical dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lajos KeményHUN-REN-SZTE Dermatological Research Group, 6720, Szeged, Hungary. kemeny.lajos@med.u-szeged.hu.ORCID http://orcid.org/0000-0002-2119-9501
Döníz DegovicsDepartment of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720, Szeged, Hungary.
Kornélia SzabóHUN-REN-SZTE Dermatological Research Group, 6720, Szeged, Hungary.

Funding

HORIZON EUROPE Global Challenges and European Industrial Competitiveness 593HORIZON EUROPE Global Challenges and European Industrial Competitiveness No. 739National Research, Development and Innovation Office OTKA K143576National Research, Development and Innovation Office TKP2021-EGA-28
6 · The paper itself

Abstract

Acne vulgaris is a chronic inflammatory skin condition with a multifactorial pathogenesis involving follicular hyperkeratinization, sebaceous gland dysregulation, microbial dysbiosis-particularly involving Cutibacterium acnes and Staphylococcus epidermidis-and complex immune-mediated mechanisms, on which T helper cell 1 (T

Indexed as

Acne VulgarisBiological ProductsDermatologic AgentsHidradenitis SuppurativaHumansSeverity of Illness IndexTreatment OutcomeTumor Necrosis Factor-alphaBiological ProductsDermatologic AgentsTumor Necrosis Factor-alpha

Identifiers

PMID40474034
PMCPMC12436545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.